BIOCOZ GLOBAL KOREA CORP has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are AIVITA BIOMEDICAL INC, BIOSOLUTION CO LTD and Yun NV.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | China | 2 | |
#4 | United States | 2 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Kim Chan Wha | 11 |
#2 | Kim Young Joon | 11 |
#3 | Kim Hyun Jung | 6 |
#4 | Kim Chan-Wha | 2 |
#5 | Yun Do Ha | 2 |
#6 | Kim Young-Joon | 2 |
#7 | Jeong Won Yong | 2 |
#8 | Lee Sang Mi | 2 |
#9 | Kim Hyun-Jung | 1 |
#10 | Kiμ Hyun Jung | 1 |
Publication | Filing date | Title |
---|---|---|
CN109195579A | Include the cosmetic composition of albumin, hyaluronic acid or collagen as active constituent in cell culture medium | |
WO2016122169A1 | Pharmaceutical composition for treating wounds or dry eye syndrome, containing neuregulin | |
WO2016122140A1 | Pharmaceutical composition for preventing or treating skin diseases, containing cell culture medium | |
CN107106459A | Being used for comprising cell culture medium, EGF and bovine serum albumin(BSA) improves the cosmetic composition of skin condition |